Gibson P R, van de Pol E, Doe W F
Department of Medicine, University of Melbourne, Royal Melbourne Hospital, Victoria, Australia.
Gut. 1991 Feb;32(2):191-5. doi: 10.1136/gut.32.2.191.
It is not known if urokinase-type plasminogen activator (uPA) is associated with normal colonic epithelial cells. The aims of this study were to determine if normal colonic epithelial cells have uPA activity and whether this is concentrated at the cell membrane. In addition, the contribution of colonic epithelial cell associated uPA activity to disease related pertubations of mucosal uPA activity were examined. A highly enriched population of colonic epithelial cells was isolated from resected colon or biopsy specimens by an enzymatic technique. uPA activity was measured in cell homogenates by a specific and sensitive colorimetric method and expressed relative to cellular DNA. In two experiments subcellular fractionation of colonic epithelial cells was performed by nitrogen cavitation followed by ultracentrifugation over a linear sucrose gradient. The fractions collected were analysed for uPA and organelle-specific enzyme activities. Normal colonic epithelial cells have cell associated uPA activity (mean (SEM) 5.6 (1.1) IU/mg, n = 18). This colocalised with fractions enriched for leucine-beta-naphthylamidase and 5'-nucleotidase, markers of plasma membrane. uPA activities in epithelial cells from cancerous colons (9.8 (3.1) n = 7) or from mucosa affected by inflammatory bowel disease (3.8 (0.7) n = 15) were not significantly different from normal (paired t test), while that in epithelial cells from greatly inflamed mucosa was similar to that from autologous normal or mildly inflamed areas (4.4 (1.2) v 5.9 (3.6), n = 9). Thus normal colonic epithelial cells have cell associated uPA activity which is concentrated on the plasma membranes, suggesting the presence of uPA receptors. Increased mucosal levels of uPA previously reported in patients with inflammatory bowel disease are not due to increased colonic epithelial cell associated uPA.
目前尚不清楚尿激酶型纤溶酶原激活剂(uPA)是否与正常结肠上皮细胞有关。本研究的目的是确定正常结肠上皮细胞是否具有uPA活性,以及这种活性是否集中在细胞膜上。此外,还研究了结肠上皮细胞相关的uPA活性对与疾病相关的黏膜uPA活性扰动的影响。通过酶技术从切除的结肠或活检标本中分离出高度富集的结肠上皮细胞群体。采用特异性灵敏的比色法测定细胞匀浆中的uPA活性,并以细胞DNA为参照进行表达。在两项实验中,通过氮气空化法对结肠上皮细胞进行亚细胞分级分离,然后在线性蔗糖梯度上进行超速离心。对收集的各组分进行uPA和细胞器特异性酶活性分析。正常结肠上皮细胞具有与细胞相关的uPA活性(平均值(标准误)为5.6(1.1)IU/mg,n = 18)。这与富含亮氨酸-β-萘胺酶和5'-核苷酸酶(质膜标志物)的组分共定位。癌性结肠上皮细胞(9.8(3.1),n = 7)或炎症性肠病累及黏膜的上皮细胞(3.8(0.7),n = 15)中的uPA活性与正常细胞无显著差异(配对t检验),而严重炎症黏膜上皮细胞中的uPA活性与自体正常或轻度炎症区域的相似(4.4(1.2)对5.9(3.6),n = 9)。因此,正常结肠上皮细胞具有与细胞相关的uPA活性,且该活性集中在质膜上,提示存在uPA受体。先前报道的炎症性肠病患者黏膜中uPA水平升高并非由于结肠上皮细胞相关uPA增加所致。